M. Harry Kane
Broad Institute(US)Nanostring Technologies (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer Diagnosis and Treatment, Systemic Sclerosis and Related Diseases, Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma(2020)792 cited
- → Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy(2020)532 cited
- → TMT Labeling for the Masses: A Robust and Cost-efficient, In-solution Labeling Approach(2019)426 cited
- → A proteogenomic portrait of lung squamous cell carcinoma(2021)369 cited
- → Heterogenized Iridium Water-Oxidation Catalyst from a Silatrane Precursor(2016)87 cited
- → Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues(2023)54 cited
- → Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes(2024)36 cited
- → Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma(2023)20 cited
- → MONTE enables serial immunopeptidome, ubiquitylome, proteome, phosphoproteome, acetylome analyses of sample-limited tissues(2021)11 cited
- → Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures(2025)3 cited